Meglutol
CARDIOVASCULAR SYSTEM
Also known as: CB-337, dicrotalic acid, lipoglutaren, medroglutaric acid, mevalon
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Meglutol is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including HMGCR.
- Molecular targets: HMGCR (1 listed in DrugCentral).
- ATC code: C10AX05 (Other lipid modifying agents).
- Molecular formula: C6H10O5; molecular weight 162.14 g/mol.
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | HMGCR | unknown | Ki 7.63 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C10AX05 | CARDIOVASCULAR SYSTEM › LIPID MODIFYING AGENTS › LIPID MODIFYING AGENTS, PLAIN › Other lipid modifying agents |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Meglutol is on its molecule page.
| Molecular formula | C6H10O5 |
|---|---|
| Molecular weight | 162.14 g/mol |
| CAS number | 503-49-1 |
| InChIKey | NPOAOTPXWNWTSH-UHFFFAOYSA-N |
| PubChem CID | 1662 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Meglutol work?
Its molecular targets in DrugCentral include HMGCR.
What is the chemical formula of Meglutol?
Meglutol has the molecular formula C6H10O5 and a molecular weight of 162.14 g/mol.
Browse: all drugs starting with M · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1670 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL50444 — compound record and bioactivity
- PubChem CID 1662 — chemical identifiers
- DrugBank DB04377 — drug record
- FDA UNII CLA99KCD53 — substance identity
- UniProt P04035 (HMGCR) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.